Goldman Sachs Group Inc Cocrystal Pharma, Inc. Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.38 - $0.55 $4,843 - $7,010	12,747 New	12,747 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.55 $4,843 - $7,010	12,747 New	12,747 $5,000
Q1 2022 May 16, 2022	SELL	$0.48 - $0.71 $8,484 - $12,549	-17,675 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.65 - $1.02 $91,180 - $143,082	-140,277 Reduced 88.81%	17,675 $11,000
Q3 2021 Nov 10, 2021	BUY	$1.01 - $1.25 $159,531 - $197,440	157,952 New	157,952 $166,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.